Some parts of the FDA’s new draft guidance for Development and Submission of NIR Analytical Procedures are reviewed and critiqued. What’s in it for spectroscopists?
Paul Smith
Advertisement
Paul Smith is EMEAI laboratory compliance productivity specialist at Agilent Technologies UK Ltd, 610 Wharefedale Road, IQ Winnersh, Wokingham, Berkshire RG41 5TP, United Kingdom, paul_smith@agilent.com
Articles by Paul Smith
Advertisement
Latest Updated Articles
Quo Vadis Regulated NIR Analytical Procedures?Published: December 1st 2015 | Updated:
Advertisement
Advertisement
Trending on Spectroscopy Online
1
Best of the Week: Advancing Energy Applications, Deep-Sea Exploration, Semiconductor Fabrication
2
Testing a New Deep Learning Model for Petroleum Analysis
3
Using Spectroscopy for Greener Recycling for Wind Turbine Waste
4
Spectroscopy Reveals Water Ice Explosive Outbursts in Comet 12P/Pons-Brooks
5
